Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
19.10
-0.30 (-1.55%)
Nov 13, 2026, 4:00 PM EST - Market closed
Artivion Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 481.88 | 441.33 | 388.54 | 354 | 313.79 | 298.84 |
Revenue Growth | 14.01% | 13.59% | 9.75% | 12.82% | 5.00% | 18.01% |
Gross Profit Gross Profit Growth | 305.09 | 284.23 | 248.78 | 229.18 | 202.52 | 197.51 |
Operating Income Operating Income Growth | 36.49 | 31.34 | 27.96 | -8.42 | -2.71 | 1.06 |
Net Income Net Income Growth | -17.64 | 9.76 | -13.34 | -30.57 | -19.09 | -14.74 |
Earnings Per Share EPS Growth | -0.37 | 0.21 | -0.32 | -0.75 | -0.48 | -0.38 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Preservation Services Preservation Services Growth | 100.45 | 95.51 | 98.31 | 92.82 | 83.44 | 77.24 |
Medical Devices Medical Devices Growth | 381.43 | 345.83 | 290.23 | 261.19 | 230.35 | 221.6 |
Total Total Growth | 481.88 | 441.33 | 388.54 | 354 | 313.79 | 298.84 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 48.4 | 64.91 | 53.46 | 58.94 | 39.35 | 55.01 |
Total Debt Total Debt Growth | 407.03 | 258.51 | 362.26 | 358.34 | 356.83 | 362.04 |
Net Cash (Debt) Net Cash Growth | -358.63 | -193.61 | -308.8 | -299.4 | -317.48 | -307.03 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.44 | -4.11 | -7.41 | -7.35 | -7.93 | -7.88 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 14.89 | 39.88 | 22.24 | 18.83 | -5.15 | -2.59 |
Capital Expenditures CapEx Growth | -59.27 | -39.04 | -11.19 | -9.75 | -10.72 | -13.09 |
Free Cash Flow Free Cash Flow Growth | -44.38 | 0.84 | 11.05 | 9.07 | -15.87 | -15.68 |
Free Cash Flow Growth | - | -92.41% | 21.77% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.31% | 64.40% | 64.03% | 64.74% | 64.54% | 66.09% |
Operating Margin | 7.57% | 7.10% | 7.20% | -2.38% | -0.86% | 0.36% |
Pretax Margin | -2.23% | 3.35% | -1.93% | -6.10% | -4.78% | -4.96% |
Profit Margin | -3.66% | 2.21% | -3.43% | -8.63% | -6.08% | -4.93% |
FCF Margin | -9.21% | 0.19% | 2.84% | 2.56% | -5.06% | -5.25% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 221.46 | - | - | - | - |
Forward PE | 178.34 | 127.40 | 280.54 | 262.49 | 262.49 | 106.05 |
P/FCF Ratio | - | 2575.41 | 108.48 | 80.89 | - | - |
PS Ratio | 1.93 | 4.90 | 3.09 | 2.07 | 1.56 | 2.68 |